文献速递泌尿生殖与妇科肿瘤放疗

前列腺癌单纯放疗后血清睾酮变化:NRG Oncology RTOG 9408 分析

Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408.
PubMed 文献 · Adv Radiat Oncol · 2017-08-03

该研究基于 NRG Oncology RTOG 9408 中接受单纯放疗的 917 例前列腺癌患者,分析放疗完成时及放疗后 3 个月的血清睾酮变化。

要点

  • 对应中位下降比例分别为 9.2% 和 9.3%,变化有统计学意义。

核心结论

  • 前列腺癌单纯放疗与血清睾酮在放疗完成时中位下降 9.2%、放疗后 3 个月中位下降 9.3% 相关,且变化有统计学意义。

研究设计与样本

  • NRG Oncology RTOG 9408 研究中接受单纯放疗的前列腺癌患者(T1b-T2b,PSA<20 ng/mL),共 917 例有基线睾酮并完成放疗。
  • 在入组时、放疗完成时及放疗后 3 个月检测血清睾酮,采用 Wilcoxon 符号秩检验比较治疗前后水平。

临床怎么用

  • 单纯放疗的前列腺癌患者应关注放疗后血清睾酮下降,尤其在评估治疗相关内分泌影响时。

局限性

  • 放疗完成时和放疗后 3 个月分别仅 447 例和 371 例有可分析的睾酮数据,样本量较基线减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We reviewed testosterone changes for patients who were treated with radiation therapy (RT) alone on NRG oncology RTOG 9408. METHODS AND MATERIALS: Patients (T1b-T2b, prostate-specific antigen <20 ng/mL) were randomized between RT alone and RT plus 4 months of androgen ablation. Serum testosterone (ST) levels were investigated at enrollment, RT completion, and the first follow-up 3 months after RT. The Wilcoxon signed rank test was used to compare pre- and post-treatment ST levels in patients who were randomized to the RT-alone arm. RESULTS: Of 2028 patients enrolled, 992 patients were randomized to receive RT alone and 917 (92.4%) had baseline ST values available and completed RT. Of these 917 patients, immediate and 3-month post-RT testosterone levels were available for 447 and 373 patients, respectively. Excluding 2 patients who received hormonal therapy off protocol after RT, 447 and 371 patients, respectively, were analyzed. For all patients, the median change in ST values at completion of RT and at 3-month follow-up were -30.0 ng/dL (p5-p95; -270.0 to 162.0; P < .001) and -34.0 ng/dL (p5-p95, -228.0 to 160.0; P < .01), respectively. CONCLUSION: RT for prostate cancer was associated with a median 9.2% decline in ST at completion of RT and a median 9.3% decline 3 months after RT. These changes were statistically significant.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Nichols RC, Hu C, Bahary JP, et al. Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408. Adv Radiat Oncol. 2017. PMID: 29204528. doi:10.1016/j.adro.2017.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。